Subsequently, we demonstrated that β-catenin overexpression reversed the effects of SETD1A knockdown on cancer stem cell property and cisplatin sensitivity of NSCLC cells (Additional file 6: Fig. S4A-C). Here, SETD1A is linked to cancer.